Therefore, we employed multiple methods to assess TGFβ, XPO4, elF5A2 and ANGPTL4 in cancerous and paracancerous liver tissue samples obtained from 280 patients suffering from liver cancer. The gene discussed is ANGPTL4; the disease is liver cancer.